Muren Huhe

Title: Muren Huhe: Innovator in Antibody Development

Introduction

Muren Huhe is a prominent inventor based in Xi'an, China. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. Her work focuses on addressing diseases related to CD147 expression, showcasing her commitment to advancing medical science.

Latest Patents

Muren Huhe holds a patent for a "Human-mouse chimeric anti-CD147 antibody with non-fucosylated glycosylation." This patent includes a nucleotide sequence comprising the sequences of SEQ ID NO: 5 and SEQ ID NO: 6, along with a vector and host cell line. The antibody binds to the extracellular region of human CD147 and features a heavy chain variable region with the amino acid sequence of SEQ ID NO: 2, and a light chain variable region with the amino acid sequence of SEQ ID NO: 1. Notably, the antibody is designed to lack both fucose and xylose residues, enhancing its therapeutic potential. The patent also covers the pharmaceutical composition comprising the antibody, methods of producing it, and its use in treating diseases related to CD147 expression.

Career Highlights

Muren Huhe is affiliated with The Fourth Military Medical University, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to antibody design and its potential impact on therapeutic applications.

Collaborations

Muren collaborates with esteemed colleagues, including Zhinan Chen and Zheng Zhang, who contribute to her research endeavors. Their combined expertise enhances the quality and scope of their projects.

Conclusion

Muren Huhe's contributions to antibody development represent a significant advancement in biotechnology. Her innovative patent and collaborative efforts position her as a key figure in the fight against CD147 expression-related diseases.